| Characteristic | Number of units sold |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Region
Spain
Survey time period
2019 to 2024
Special properties
Considers Mounjaro, Ozempic, Rybelsus, Saxenda and Wegovy sales
Citation formats









